Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | KDM4A | O75164 | 3/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | KDM5A | P29375 | 1/20 | 0.35 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.35 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.35 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7282265 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1FAAHTRPV1 | |
| SCHEMBL7294715 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1FAAHTRPV1 | |
| SCHEMBL7284860 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1FAAHTRPV1 | |
| SCHEMBL7291004 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1FAAHTRPV1 | |
| SCHEMBL18807792 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1FAAHTRPV1 | |
| SCHEMBL7285272 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1FAAHTRPV1 | |
| SCHEMBL951795 | 1.00 | TSHR (0.58) | TSHRALDH1A1DNM1FAAHTRPV1 | |
| Iodide SCHEMBL25402951 | 0.97 | TSHR (0.55) | TSHRALDH1A1DNM1FAAHTRPV1 | |
| SCHEMBL5226044 | 0.97 | TSHR (0.55) | TSHRALDH1A1DNM1FAAHTRPV1 | |
| Bromide SCHEMBL25406243 | 0.97 | TSHR (0.55) | TSHRALDH1A1DNM1FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116057130-B | Branched amino acid surfactants for inks, coatings and adhesives | 艾德凡斯化学公司 | 2024-05-28 | — | — | CN | claimed |
| CN-116113398-A | Branched chain amino acid surfactant for health care products | 艾德凡斯化学公司 | 2023-05-12 | — | — | CN | claimed |
| CN-116059394-A | anti-EGFR antibody drug conjugates | 艾伯维公司 | 2023-05-05 | — | — | CN | claimed |
| CN-116059202-A | anti-EGFR antibody drug conjugates | 艾伯维公司 | 2023-05-05 | — | — | CN | claimed |
| CN-116057041-A | Branched chain amino acid surfactants | 艾德凡斯化学公司 | 2023-05-02 | — | — | CN | claimed |
| US-20260035392-A1 | SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES | ADVANSIX RESINS & CHEMICALS LLC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12466846-B2 | Siloxane derivatives of amino acids having surface-active properties | ADVANSIX RESINS & CHEMICALS LLC (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250130225-A1 | SUBSTRATES FOR IMAGING GLUCOCEREBROSIDASE ACTIVITY | SIMON FRASER UNIVERSITY (CA) | 2025-04-24 | — | — | US | disclosed |
| US-20250057955-A1 | SURFACTANTS FOR USE IN HEALTHCARE PRODUCTS | ADVANSIX RESINS & CHEMICALS LLC (US) | 2025-02-20 | — | — | US | disclosed |
| US-20250057749-A1 | SURFACTANTS FOR USE IN PERSONAL CARE AND COSMETIC PRODUCTS | ADVANSIX RESINS & CHEMICALS LLC (US) | 2025-02-20 | — | — | US | disclosed |
| US-20250051643-A1 | SURFACTANTS FOR ELECTRONICS | ADVANSIX RESINS & CHEMICALS LLC (US) | 2025-02-13 | — | — | US | disclosed |
| CN-116057130-B | Branched amino acid surfactants for inks, coatings and adhesives | 艾德凡斯化学公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-0446751-A1 | Glycolic acid derivatives | MERCK PATENT GmbH (DE) | 1991-09-18 | — | — | EP | disclosed |
| EP-0446485-A2 | Peptide analogues with renininhibiting activity | MERCK PATENT GmbH (DE) | 1991-09-18 | — | — | EP | disclosed |
| EP-0418696-A2 | Derivatives of aminoacids | MERCK PATENT GmbH (DE) | 1991-03-27 | — | — | EP | disclosed |
| CN-1037155-A | Amino acid derivative | MERCK PATENT GMBH (DE) | 1989-11-15 | — | — | CN | disclosed |
| EP-0339483-A2 | Renin inhbiting amino-acid derivatives | MERCK PATENT GmbH (DE) | 1989-11-02 | — | — | EP | disclosed |
| EP-0337334-A2 | Renin-inhibiting amino acid derivatives | MERCK PATENT GmbH (DE) | 1989-10-18 | — | — | EP | disclosed |
| EP-0309841-A2 | Amino acid derivatives | MERCK PATENT GmbH (DE) | 1989-04-05 | — | — | EP | disclosed |
| EP-0297496-A2 | Novel process for the preparation of 6,7-Diacyl-7-deacetylforskolin derivatives | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1989-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057749-A1 | SURFACTANTS FOR USE IN PERSONAL CARE AND COSMETIC PRODUCTS | CUTA, SMURF1, PLOD3 | TSHR 1489/4885ALDH1A1 3081/4885DNM1 858/4885 |
| US-20250051643-A1 | SURFACTANTS FOR ELECTRONICS | STOM, ESPL1, SMURF1 | TSHR 3113/4885ALDH1A1 4356/4885DNM1 679/4885 |
| US-20250130225-A1 | SUBSTRATES FOR IMAGING GLUCOCEREBROSIDASE ACTIVITY | GAA, GBA3, GBA1 | TSHR 4418/4885ALDH1A1 760/4885DNM1 2075/4885 |
| US-12466846-B2 | Siloxane derivatives of amino acids having surface-active properties | BCAT1, PCMT1, LTN1 | TSHR 4450/4885ALDH1A1 4398/4885DNM1 2592/4885 |
| US-20260035392-A1 | SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES | BCAT1, BCAT2, SLC43A1 | TSHR 2235/4885ALDH1A1 1960/4885DNM1 2691/4885 |
| US-20250057955-A1 | SURFACTANTS FOR USE IN HEALTHCARE PRODUCTS | S100P, DSG1, TMSB10 | TSHR 3295/4885ALDH1A1 4436/4885DNM1 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.